Scholars@Duke

Lessons learned from HIV-1 vaccine trials: new priorities and directions.

Publication ,  Journal Article
McMichael, AJ; Haynes, BF
Published in: Nat Immunol
April 18, 2012
Published version (DOI) Link to item

A vaccine against human immunodeficiency virus (HIV) seems to be on the horizon. Correlates of risk of infection for [corrected] the RV144 vaccine trial have been found. There is understanding of what makes HIV envelope-specific antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability.

Duke Scholars

Barton Ford Haynes
Author Barton Ford Haynes Medicine, Duke Human Vaccine Institute
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Immunol

DOI

10.1038/ni.2264

EISSN

1529-2916

Publication Date

April 18, 2012

Volume

13

Issue

5

Start / End Page

423 / 427

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • T-Lymphocytes
  • Macaca mulatta
  • Immunology
  • Immunoglobulin G
  • Immunoglobulin A
  • Humans
  • HIV-1
  • HIV Infections
  • Clinical Trials as Topic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McMichael, A. J., & Haynes, B. F. (2012). Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat Immunol, 13(5), 423–427. https://doi.org/10.1038/ni.2264
McMichael, Andrew J., and Barton F. Haynes. “Lessons learned from HIV-1 vaccine trials: new priorities and directions.” Nat Immunol 13, no. 5 (April 18, 2012): 423–27. https://doi.org/10.1038/ni.2264.
McMichael AJ, Haynes BF. Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat Immunol. 2012 Apr 18;13(5):423–7.
McMichael, Andrew J., and Barton F. Haynes. “Lessons learned from HIV-1 vaccine trials: new priorities and directions.” Nat Immunol, vol. 13, no. 5, Apr. 2012, pp. 423–27. Pubmed, doi:10.1038/ni.2264.
McMichael AJ, Haynes BF. Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat Immunol. 2012 Apr 18;13(5):423–427.

Published In

Nat Immunol

DOI

10.1038/ni.2264

EISSN

1529-2916

Publication Date

April 18, 2012

Volume

13

Issue

5

Start / End Page

423 / 427

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • T-Lymphocytes
  • Macaca mulatta
  • Immunology
  • Immunoglobulin G
  • Immunoglobulin A
  • Humans
  • HIV-1
  • HIV Infections
  • Clinical Trials as Topic